Of mice and men: A vaccine composed of the fully synthetic globo H human breast tumor antigen 1 and a carrier protein elicits the formation of IgM antibodies in mice. These antibodies bind to MCF-7 breast cancer cells and trigger effective complement-mediated cell lysis. These promising results from the immune system of the mouse prompts a strategy to foster active immunity in humans.
No takes yet. Share an insight, caveat, or question.
Ragupathi et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: